Thereby, downregulation of DNMT exhibits a stimulatory effect on the expression of miR‐34a, highlighting its prospective utility as a therapeutic target for pancreatic cancer [72]. The gene discussed is DNMT1; the disease is familial pancreatic carcinoma.